LAMEA Pyrogen Testing Market Size, Share & Trends Analysis Report By Product & Service (Reagents & Kits, Services, and Instruments), By Test Type (LAL Test, Rabbit Pyrogen Test, and Others), By End User, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Pyrogen Testing Market would witness market growth of 9.8% CAGR during the forecast period (2023-2030).

There is a growing interest in the development of point-of-care testing solutions. These portable and rapid testing platforms allow on-site testing, enabling timely decision-making during manufacturing processes and reducing the time-to-market for pharmaceutical and medical device products. One of the defining features of these solutions is their ability to deliver rapid results. Point-of-care testing platforms are designed for swift analysis, providing manufacturers with immediate feedback on the presence of pyrogens in their products. This rapid turnaround time is instrumental in making timely decisions during the production cycle.

In addition, advances in biotechnology, including the use of recombinant technologies, are influencing these testing methodologies. Recombinant reagents and cells engineered for pyrogen detection contribute to developing more standardized and reproducible testing methods. Recombinant technologies allow for precisely engineering molecules that can specifically recognize pyrogenic substances. The increased accuracy of this precision reduces the probability of false positives or false negatives that could arise with conventional techniques.

The growth of the medical equipment sector in Brazil is likely to result in an increased production of various medical devices. As the production volume rises, the demand for this testing will also grow to ensure these devices meet rigorous safety and quality standards. As per the data from the International Trade Administration, Brazil is the largest medical equipment sector in South America and is still growing. Medical equipment and in vitro diagnostics revenue in 2021 reached an estimated USD 7.5 billion. According to the World Bank, in 2021, Brazil's private and public healthcare expenses comprised 9.1% of Brazil’s GDP. Hence, the expansion of medical devices sector in LAMEA will assist in the growth of the regional market.

The Brazil market dominated the LAMEA Pyrogen Testing Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $49.4 Million by 2030. The Argentina market is showcasing a CAGR of 10.6% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 9.5% during (2023 - 2030).

Based on Product & Service, the market is segmented into Reagents & Kits, Services, and Instruments. Based on Test Type, the market is segmented into LAL Test, Rabbit Pyrogen Test, and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Companies, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Merck KGaA
• Charles River Laboratories International, Inc.
• Genscript Biotech Corporation
• WuXi AppTec Co., Ltd.
• Lonza Group Ltd.
• Fujifilm Holdings Corporation
• Eurofins Scientific SE
• Thermo Fisher Scientific, Inc.
• Seikagaku Corp.
• InvivoGen SAS

Market Report Segmentation

By Product & Service

• Reagents & Kits
• Services
• Instruments

By Test Type

• LAL Test
• Rabbit Pyrogen Test
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA